GDF2026 - Q&A Discussion Panel Four and Day One Closing
FDA workshop panel on Product-Specific Guidance (PSG) and generics · July 30, 2026
FDA workshop Q&A on product-specific guidances (PSGs) covered alternatives for discontinued reference products, PSG timelines and prioritization under GDUFA, archive policy for old PSGs, device-related standards (USP <382>), and when revised PSGs apply to pending responses.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.
